Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Angiotensin Receptor Blockers Effect on Serum Uric Acid-A Class Effect?

Sutton Burke EM, Kelly TC, Shoales LA, Nagel AK.

J Pharm Pract. 2019 Aug 7:897190019866315. doi: 10.1177/0897190019866315. [Epub ahead of print]

PMID:
31390929
2.

Patient Experience With Care and Its Association With Adherence to Hypertension Medications.

Fortuna RJ, Nagel AK, Rocco TA, Legette-Sobers S, Quigley DD.

Am J Hypertens. 2018 Feb 9;31(3):340-345. doi: 10.1093/ajh/hpx200.

PMID:
29253071
3.

SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?

Ahmed-Sarwar N, Nagel AK, Leistman S, Heacock K.

Ann Pharmacother. 2017 Sep;51(9):791-796. doi: 10.1177/1060028017710481. Epub 2017 May 23. Review.

PMID:
28535688
4.

Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice.

Fortuna RJ, Nagel AK, Rose E, McCann R, Teeters JC, Quigley DD, Bisognano JD, Legette-Sobers S, Liu C, Rocco TA.

J Am Soc Hypertens. 2015 Dec;9(12):966-74. doi: 10.1016/j.jash.2015.10.004. Epub 2015 Oct 26.

PMID:
26687551
5.

Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database.

Nagel AK, Ahmed-Sarwar N, Werner PM, Cipriano GC, Van Manen RP, Brown JE.

Ann Pharmacother. 2016 Jan;50(1):27-31. doi: 10.1177/1060028015610123. Epub 2015 Oct 23.

PMID:
26497885
6.

Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics.

Williams GR, Bethard JR, Berkaw MN, Nagel AK, Luttrell LM, Ball LE.

Methods. 2016 Jan 1;92:36-50. doi: 10.1016/j.ymeth.2015.06.022. Epub 2015 Jul 6.

7.

Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.

Nagel AK, Ball LE.

Adv Cancer Res. 2015;126:137-66. doi: 10.1016/bs.acr.2014.12.003. Epub 2015 Feb 7. Review.

PMID:
25727147
8.

O-GlcNAc modification of the runt-related transcription factor 2 (Runx2) links osteogenesis and nutrient metabolism in bone marrow mesenchymal stem cells.

Nagel AK, Ball LE.

Mol Cell Proteomics. 2014 Dec;13(12):3381-95. doi: 10.1074/mcp.M114.040691. Epub 2014 Sep 3.

9.

O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.

Nagel AK, Ball LE.

Amino Acids. 2014 Oct;46(10):2305-16. doi: 10.1007/s00726-014-1827-7. Epub 2014 Aug 31. Review.

10.

A Review of Current Evidence of Olmesartan Medoxomil Mimicking Symptoms of Celiac Disease.

Sanford ML, Nagel AK.

J Pharm Pract. 2015 Apr;28(2):189-192. Epub 2014 Mar 28.

PMID:
24682568
11.

Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation.

Nagel AK, Schilling M, Comte-Walters S, Berkaw MN, Ball LE.

Mol Cell Proteomics. 2013 Apr;12(4):945-55. doi: 10.1074/mcp.M112.026633. Epub 2013 Feb 26.

12.

Duemmler, Kerstin; Nagel, Alexander-Kenneth: governing religious diversity: top-down and bottom-up initiatives in Germany and Switzerland.

Duemmler K, Nagel AK.

Integr Psychol Behav Sci. 2013 Jun;47(2):265-83. doi: 10.1007/s12124-012-9226-7.

PMID:
23271375

Supplemental Content

Loading ...
Support Center